HomeOGN • BMV
add
Organon & Co
Previous close
$131.30
Year range
$113.00 - $327.00
Market cap
1.90B USD
Avg Volume
3.00
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.51B | -5.34% |
Operating expense | 522.00M | -11.38% |
Net income | -205.00M | -288.07% |
Net profit margin | -13.60 | -298.54% |
Earnings per share | 0.63 | -30.00% |
EBITDA | 340.00M | -11.46% |
Effective tax rate | -38.51% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 574.00M | -14.96% |
Total assets | 12.87B | -1.79% |
Total liabilities | 12.12B | -4.07% |
Total equity | 752.00M | — |
Shares outstanding | 260.32M | — |
Price to book | 45.43 | — |
Return on assets | 4.62% | — |
Return on capital | 6.33% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -205.00M | -288.07% |
Cash from operations | 141.00M | -63.85% |
Cash from investing | -65.00M | 78.04% |
Cash from financing | -187.00M | -128.05% |
Net change in cash | -98.00M | -11.36% |
Free cash flow | 64.88M | -76.36% |
About
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
Founded
1923
Headquarters
Website
Employees
10,000
